Consolidated Statement Of Cash Flows

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7324025

Concept 2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
As at
2022-03-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
5,903,000,000 JPY
13,240,000,000 JPY
Interest and dividends received
479,000,000 JPY
439,000,000 JPY
Interest paid
-17,000,000 JPY
-17,000,000 JPY
Net cash provided by (used in) operating activities
2,577,000,000 JPY
9,253,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-1,861,000,000 JPY
-1,987,000,000 JPY
Proceeds from sale of property, plant and equipment
1,000,000 JPY
12,000,000 JPY
Purchase of investment securities
JPY
-200,000,000 JPY
Net cash provided by (used in) investing activities
-5,854,000,000 JPY
-2,627,000,000 JPY
Proceeds from sale of investment securities
516,000,000 JPY
5,000,000 JPY
Other, net
-22,000,000 JPY
-18,000,000 JPY
Cash flows from financing activities
Dividends paid
-5,657,000,000 JPY
-5,649,000,000 JPY
Net cash provided by (used in) financing activities
-5,658,000,000 JPY
-6,990,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
JPY
JPY
Net increase (decrease) in cash and cash equivalents
-8,935,000,000 JPY
-364,000,000 JPY
Cash and cash equivalents
65,325,000,000 JPY
74,260,000,000 JPY
74,625,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.